HIVMA praises passage of the HOPE Act, urges swift enactment into law

November 13, 2013

The U.S. Congress took an important step Tuesday evening with House passage of the HIV Organ Policy Equity (HOPE) Act, which will allow research on donation of organs from deceased HIV-infected donors to HIV-infected recipients. Having been passed by the Senate in June, the bill is now positioned to move to the White House to be signed into law. The HOPE Act modernizes outdated federal law to reflect the current medical understanding of HIV infection and to allow for scientific research. As HIV clinicians and researchers, we applaud Congressional passage of the Act and look forward to its swift enactment after it is signed by the President.

For patients living with HIV, deceased donors with the same infection represent a unique source of organs. Passage of the HOPE Act will save the lives of hundreds of HIV-infected patients struggling with liver and kidney failure each year. Until enactment of the HOPE Act, research necessary to explore the feasibility of such transplants was banned under .

Currently, an estimated 6,500 people die each year while waiting for organ transplants. This legislation will significantly reduce that number for both HIV-infected and HIV-negative patients because of the larger pool of organs available. Passage of the HOPE Act will also reduce costs to Medicare for dialysis treatment of end-stage kidney disease, while protecting public health by maintaining provisions that are critical to safe organ procurement and allocation.

The HIV Medicine Association (HIVMA) applauds the HOPE Act's co-sponsors and supporters, in particular Senators Barbara Boxer (D-CA) and Tom Coburn (R-OK), and Representatives Lois Capps (D-CA-24th), Andy Harris (R-MD-1st) and Michael Burgess (R-TX-26th), and looks forward to the bill's enactment into law and to working with the administration to swiftly implement this life-saving measure. For more information, see HIVMA's related FAQ and policy statement.

Explore further: HIV-infected donors present novel source of organs for HIV-infected transplant candidates

Related Stories

HIV-infected donors present novel source of organs for HIV-infected transplant candidates

May 23, 2011
A new study published in the American Journal of Transplantation reveals that HIV-infected deceased donors represent a potentially novel source of organs for HIV-infected transplant candidates that could decrease waitlist ...

Mayo Clinic makes kidney and pancreas transplant available to HIV-infected patients

December 6, 2011
Mayo Clinic in Florida is now offering kidney and pancreas transplants to HIV positive patients with advanced kidney disease and diabetes. Evidence is now solid that HIV-positive patients have the same favorable outcome in ...

'High-risk' organs from deceased donors safe when screened with current methods

October 25, 2013
Approximately 10% of deceased donor kidneys are considered "high-risk" for infection (HIV, HCV, HBV) and disease transmission according to criteria set by the Centers for Disease Control and Prevention. But new research suggests ...

Nail fungus drug might help against HIV, study suggests

September 24, 2013
(HealthDay)—A common drug used to treat nail fungus may hold promise against HIV, the virus that causes AIDS, according to a new study.

Recommended for you

Scientists divulge latest in HIV prevention

July 25, 2017
A far cry from the 1990s "ABC" campaign promoting abstinence and monogamy as HIV protection, scientists reported on new approaches Tuesday allowing people to have all the safe sex they want.

Girl's HIV infection seems under control without AIDS drugs

July 24, 2017
A South African girl born with the AIDS virus has kept her infection suppressed for more than eight years after stopping anti-HIV medicines—more evidence that early treatment can occasionally cause a long remission that, ...

Meds by monthly injection might revolutionize HIV care (Update)

July 24, 2017
Getting a shot of medication to control HIV every month or two instead of having to take pills every day could transform the way the virus is kept at bay.

Candidate AIDS vaccine passes early test

July 24, 2017
The three-decade-old quest for an AIDS vaccine received a shot of hope Monday when developers announced that a prototype triggered the immune system in an early phase of human trials.

Paris spotlight on latest in AIDS science

July 21, 2017
Some 6,000 HIV experts gather in Paris from Sunday to report advances in AIDS science as fading hopes of finding a cure push research into new fields.

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.